Bolar Pharm. Co. v. Roche Prods., Inc., 469 U.S. 856 (1984). · Go Syfert
Search
Bolar Pharm. Co. v. Roche Prods., Inc., 469 U.S. 856 (1984). Cases Citing This Book View Copy Cite
G Cite
cited 2× by 1 distinct case, last quoted 1987 · …trial court ... has considerable discretion in determining whether ... to issue an injunction ⚠ not in text
61 citation events (11 in the last 25 years) across 20 distinct courts.
Strongest positive: H.H. Robertson, Company v. United Steel Deck, Inc. And Nicholas J. Bouras, Inc. (cafc, 1987-05-27)
Treatment trajectory · 1985 → 2026 · click a year to view as-of
1985 2005 2026
Top citers, strongest first. 7 distinct citers. How cited ↗
examined Cited as authority (quoted) H.H. Robertson, Company v. United Steel Deck, Inc. And Nicholas J. Bouras, Inc. (2×)
Fed. Cir. · 1987 · signal: see also · quote attribution · 2 verbatim quotes · confidence low
trial court ... has considerable discretion in determining whether ... to issue an injunction
cited Cited "see" Allele Biotechnology and Pharmaceuticals, Inc. v. Pfizer, Inc.
S.D. Cal. · 2021 · signal: see · confidence high
See Roche Products, Inc. v. Bolar Pharmaceutical 27 Co., 733 F.2d 858 , cert. denied, 469 U.S. 856 , 105 S. Ct. 183 , 83 L.Ed.2d 117 (1984).
discussed Cited "see" SmithKline Beecham Corp. v. Geneva Pharmaceuticals, Inc.
E.D. Pa. · 2002 · signal: see · confidence high
See Roche Products, Inc. v. Bolar Pharmaceutical Co., 733 F.2d 858 , cert. denied, 469 U.S. 856 , 105 S.Ct. 183 , 83 L.Ed.2d 117 (1984). [Footnote omitted] Since that activity could not be commenced by those who planned to compete with the patentee until expiration of the entire patent term, the patentee’s de facto monopoly would continue for an often substantial period until regulatory approval was obtained.
cited Cited "see" Abbott Laboratories v. Zenith Laboratories, Inc.
N.D. Ill. · 1995 · signal: see · confidence high
See Roche Products, Inc. v. Bolar Pharmaceutical Co., 733 F.2d 858 , cert. denied, 469 U.S. 856 , 105 S.Ct. 183 , 83 L.Ed.2d 117 (1984).
discussed Cited "see" Dow Chemical Co. v. United States
Fed. Cl. · 1994 · signal: see · confidence high
See Roche Prods, v. Bolar Pharmaceutical Co., 733 F.2d 858, 861 , cert, denied, 469 U.S. 856 , 105 S.Ct. 183 , 83 L.Ed.2d 117 (1984); Pitcairn v. United States, 212 Ct.Cl. 168 , 547 F.2d 1106 (1976), cert, denied, 434 U.S. 1051 , 98 S.Ct. 903 , 54 L.Ed.2d 804 (1978); Douglas v. United States, 181 USPQ 170 , 1974 WL 20548 (Ct.Cl.
discussed Cited "see" Yarway Corporation v. Eur-Control Usa, Inc., and Eur-Control Kalle, A.B. (2×)
Fed. Cir. · 1985 · signal: see · confidence high
See Perkin-Elmer Corp. v. Computervision Corp., 732 F.2d 888, 900 , 221 USPQ 669, 678 (Fed.Cir.), cert. denied, — U.S.-, 105 S.Ct. 187 , 83 L.Ed.2d 120 , 225 USPQ 792 (1984).
cited Cited "see" United States v. Alejandrina Torres
7th Cir. · 1985 · signal: see · confidence high
See 105 S.Ct. 183 .
Retrieving the full opinion text from the archive…
Bolar Pharmaceutical Co., Inc.
v.
Roche Products, Inc.
No. 84-130.
Supreme Court of the United States.
Oct 1, 1984.
469 U.S. 856
Cited by 1 opinion  |  Published
1 passages pin-cited by 1 case
Pinpoint authority: bottom 66%
Citer courts: Federal Circuit (2)

C. A. Fed. Cir. Certiorari denied.